Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-31 4:10 pm Purchase |
2025-03-24 | 13G | Opus Genetics, Inc. IRD |
PERCEPTIVE ADVISORS LLC | 4,510,501 9.990% |
4,510,501 (New Position) |
Filing History |
| 2024-10-29 5:26 pm Purchase |
2024-10-22 | 13D | Opus Genetics, Inc. IRD |
Foundation Fighting Blindness Retinal Degeneration Fund | 2,564,752 8.160% |
2,564,752 (New Position) |
Filing History |
| 2023-02-14 3:23 pm Sale |
2022-12-31 | 13G | Opus Genetics, Inc. IRD |
Sooch Mina | 1,187,352 5.500% |
-98,910 (-7.69%) |
Filing History |
| 2022-05-17 4:37 pm Purchase |
2022-04-12 | 13G | Opus Genetics, Inc. IRD |
Richmond Brothers Inc. | 1,193,633 6.200% |
776,219 (+185.96%) |
Filing History |
| 2022-02-14 4:10 pm Unchanged |
2021-12-31 | 13G | Opus Genetics, Inc. IRD |
Sooch Mina | 1,286,262 6.700% |
0 (Unchanged) |
Filing History |
| 2022-02-14 09:53 am Unchanged |
2021-12-31 | 13G | Opus Genetics, Inc. IRD |
Altium Capital Management LLC | 2,678,883 4.990% |
0 (Unchanged) |
Filing History |
| 2022-01-18 11:17 am Purchase |
2021-12-31 | 13G | Opus Genetics, Inc. IRD |
Empery Asset Management, LP | 3,063,498 4.990% |
384,615 (+14.36%) |
Filing History |
| 2021-03-26 4:05 pm Purchase |
2020-11-06 | 13G | Opus Genetics, Inc. IRD |
Apexian Pharmaceuticals Inc. | 779,993 7.136% |
779,993 (New Position) |
Filing History |
| 2021-03-16 7:58 pm Purchase |
2020-12-31 | 13G | Opus Genetics, Inc. IRD |
Sooch Mina | 1,286,262 11.800% |
1,286,262 (New Position) |
Filing History |
| 2021-02-16 09:17 am Purchase |
2020-12-31 | 13G | Opus Genetics, Inc. IRD |
Altium Capital Management LLC | 2,678,883 9.990% |
2,087,867 (+353.27%) |
Filing History |
| 2021-02-02 10:26 am Purchase |
2020-12-31 | 13G | Opus Genetics, Inc. IRD |
Empery Asset Management, LP | 2,678,883 9.990% |
2,087,867 (+353.27%) |
Filing History |
| 2020-11-16 2:21 pm Purchase |
2020-11-06 | 13G | Opus Genetics, Inc. IRD |
Richmond Brothers Inc. | 417,414 5.800% |
417,414 (New Position) |
Filing History |
| 2020-11-16 2:00 pm Purchase |
2020-11-05 | 13G | Opus Genetics, Inc. IRD |
Altium Capital Management LLC | 591,016 8.300% |
591,016 (New Position) |
Filing History |
| 2020-11-12 10:38 am Purchase |
2020-11-05 | 13G | Opus Genetics, Inc. IRD |
Empery Asset Management, LP | 591,016 8.330% |
591,016 (New Position) |
Filing History |
| 2020-08-10 5:02 pm Purchase |
2020-07-31 | 13G | REXAHN PHARMACEUTICALS INC REXN |
Armistice Capital, LLC | 44,145 1.000% |
44,145 (New Position) |
Filing History |